ClinicalTrials.Veeva

Menu

Spectrum Analysis in Ex-vivo Human Lungs

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

Lung Cancer

Treatments

Device: Spectrum Analysis

Study type

Interventional

Funder types

Other

Identifiers

NCT03356743
16-6177

Details and patient eligibility

About

This study will analyze spectral features of the radiofrequency of lung tumors in ex-vivo human lungs. The resected specimens will be evaluated using the spectrum analysis to determine the localization rate of the targets. Ultrasound measurement and images will be used for correlation of TS mode image findings with pathology by using HE and IHC slides of lung tumor and lymph node.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patients scheduled for lobectomy of anatomical segmental resection for malignant lung tumors.
  • 18 years of age or older

Exclusion criteria

  • Any patients with inability to give informed consent.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Ex-Vivo
Experimental group
Treatment:
Device: Spectrum Analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems